ARCH Venture Fund IX, L.P.

Entity
Company
Business address
8755 W. Higgins Road, Suite 1025, 60631 Chicago, IL
Phone
773-380-6600
State of incorporation
DE
Fiscal year end
December 31
13D/G Schedule signature
Robert Nelsen - Mark McDonnell as Attorney-in-Fact for Robert Nelsen
Insider ownership signature
/s/ ARCH Venture Fund X Overage, L.P., By: ARCH Venture Partners X Overage, L.P., its General Partner, By: ARCH Venture Partners X, LLC, its General Partner, By: Mark McDonnell, attorney in-fact
All SEC filings
View on sec.gov
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
ARCH Venture Fund IX, L.P. has filed 71 SEC EDGAR filings since 3/17/2016

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
SCHEDULE 13G/A Open Document Open Filing Nov 14, 2025
SCHEDULE 13G/A Open Document Open Filing Nov 14, 2025
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Jul 29, 2025 Jul 25, 2025 001-40502
SCHEDULE 13G/A Open Document Open Filing May 15, 2025
SCHEDULE 13G/A Open Document Open Filing May 15, 2025
CORRESP Open Document Open Filing Feb 24, 2025
SCHEDULE 13G/A Open Document Open Filing Feb 14, 2025
SCHEDULE 13G/A Open Document Open Filing Feb 14, 2025
SC 13G/A Open Document Open Filing ARCH VENTURE FUND IX, L.P. - SANA BIOTECHNOLOGY -- SCH 13G/A(#3) Nov 14, 2024
SC 13D Open Document Open Filing ARCH VENTURE FUND IX, L.P. - BOUNDLESS BIO -- SCH 13D Oct 29, 2024
4 Open Document Open Filing 4 Apr 4, 2024 Apr 2, 2024 001-41989
3 Open Document Open Filing 3 Mar 27, 2024 Mar 27, 2024 001-41989
SC 13G/A Open Document Open Filing ARCH VENTURE FUND IX, L.P. - LYELL IMMUNOPHARMA -- SCH 13G/A(#1) Feb 14, 2024
SC 13G/A Open Document Open Filing ARCH VENTURE FUND IX, L.P. - BEAM THERAPEUTICS -- SCH 13G/A(#2) Feb 14, 2024
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Feb 12, 2024 Feb 8, 2024 001-39941
SC 13G/A Open Document Open Filing ARCH VENTURE FUND IX, L.P. - SANA BIOTECHNOLOGY -- SCH 13G/A(#2) Feb 9, 2024
SC 13G/A Open Document Open Filing ARCH VENTURE FUND IX, L.P. - GOSSAMER BIO -- SCH 13G/A(#1-EXIT) Feb 9, 2024
SC 13G/A Open Document Open Filing ARCH VENTURE FUND IX, L.P. - SANA BIOTECHNOLOGY -- SCH 13G/A(#1) Feb 13, 2023
SC 13D/A Open Document Open Filing ARCH VENTURE FUND IX, L.P. -- KARUNA THERAPEUTICS -- SCHEDULE 13DA(4E) Sep 20, 2022
SC 13D/A Open Document Open Filing ARCH VENTURE FUND IX, L.P. -- VIR BIOTECHNOLOGY, INC. -- SCHEDULE 13DA(#6) Sep 13, 2022
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Sep 7, 2022 Sep 2, 2022 001-39083
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Sep 1, 2022 Aug 30, 2022 001-39083
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Aug 26, 2022 Aug 24, 2022 001-39083
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Aug 22, 2022 Aug 18, 2022 001-39083
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Aug 16, 2022 Aug 12, 2022 001-39083
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Jun 10, 2022 Jun 8, 2022 001-39083
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Jun 6, 2022 Jun 2, 2022 001-39083
SC 13D/A Open Document Open Filing ARCH VENTURE FUND IX, L.P. -- VIR BIOTECHNOLOGY, INC. -- SCHEDULE 13DA(#5) May 10, 2022
SC 13G/A Open Document Open Filing ARCH VENTURE FUND IX, L.P. - BEAM THERAPEUTICS -- SCH 13G/A(#1) Feb 14, 2022
SC 13G Open Document Open Filing ARCH VENTURE FUND IX, L.P. - LYELL IMMUNOPHARMA -- SCH 13G Feb 14, 2022
SC 13G Open Document Open Filing ARCH VENTURE FUND IX, L.P. - SANA BIOTECHNOLOGY -- SCH 13G Feb 10, 2022
SC 13G Open Document Open Filing ARCH VENTURE FUND IX, L.P. - SINGULAR GENOMICS SYSTEMS -- SCH 13G Feb 4, 2022
SC 13D/A Open Document Open Filing ARCH VENTURE FUND IX, L.P. -- VIR BIOTECHNOLOGY, INC. -- SCHEDULE 13DA(#4) Jan 10, 2022
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Dec 22, 2021 Dec 20, 2021 001-39083
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Dec 1, 2021 Nov 29, 2021 001-39083
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Nov 24, 2021 Nov 22, 2021 001-39083
SC 13D/A Open Document Open Filing ARCH VENTURE FUND IX, L.P. -- VIR BIOTECHNOLOGY, INC. -- SCHEDULE 13DA(#3) Jul 12, 2021
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Jul 6, 2021 Jul 1, 2021 001-39083
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Jul 2, 2021 Jun 30, 2021 001-39208
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Jun 29, 2021 Jun 25, 2021 001-39208
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Jun 24, 2021 Jun 22, 2021 001-39083
4 Open Document Open Filing FORM 4 SUBMISSION Jun 23, 2021 Jun 21, 2021 001-40502
3 Open Document Open Filing FORM 3 SUBMISSION Jun 16, 2021 Jun 16, 2021 001-40502
SC 13D/A Open Document Open Filing ARCH VENTURE FUND IX, L.P. -- KARUNA THERAPEUTICS -- SCHEDULE 13DA(3) Apr 23, 2021
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Apr 15, 2021 Apr 13, 2021 001-38958
SC 13D/A Open Document Open Filing ARCH VENTURE FUND IX, L.P. -- VIR BIOTECHNOLOGY, INC. -- SCHEDULE 13DA(#2) Apr 14, 2021
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Apr 9, 2021 Apr 7, 2021 001-39083
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Apr 2, 2021 Mar 31, 2021 001-39208
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Apr 1, 2021 Mar 30, 2021 001-39083
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Mar 22, 2021 Mar 18, 2021 001-39208
4 Open Document Open Filing FORM 4 SUBMISSION Feb 10, 2021 Feb 8, 2021 001-39941
3 Open Document Open Filing FORM 3 SUBMISSION Feb 3, 2021 Feb 3, 2021 001-39941
SC 13G Open Document Open Filing ARCH VENTURE FUND IX, L.P. - BEAM THERAPEUTICS -- SCH 13G Feb 2, 2021
SC 13D/A Open Document Open Filing ARCH VENTURE FUND IX, L.P. -- KARUNA THERAPEUTICS -- SCHEDULE 13DA(2) Jan 19, 2021
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Jan 12, 2021 Jan 8, 2021 001-38958
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Nov 16, 2020 Nov 12, 2020 001-38958
SC 13D/A Open Document Open Filing ARCH VENTURE FUND IX, L.P. -- VIR BIOTECHNOLOGY, INC. -- SCHEDULE 13DA(1) Jul 29, 2020
SC 13G Open Document Open Filing ARCH VENTURE FUND IX, L.P. - GOSSAMER BIO, INC. -- SCHEDULE 13G Feb 13, 2020
4 Open Document Open Filing FORM 4 SUBMISSION Feb 11, 2020 Feb 10, 2020 001-39208
3 Open Document Open Filing FORM 3 SUBMISSION Feb 5, 2020 Feb 5, 2020 001-39208
SC 13D/A Open Document Open Filing ARCH VENTURE FUND IX, L.P. - SCHEDULE 13D/A(#1) - KARUNA THERAPEUTICS, INC. Dec 13, 2019
SC 13D Open Document Open Filing ARCH VENTURE FUND IX, L.P. - SCHEDULE 13D - VIR BIOTECHNOLOGY, INC. Nov 8, 2019
4 Open Document Open Filing FORM 4 SUBMISSION Oct 18, 2019 Oct 16, 2019 001-39083
3 Open Document Open Filing FORM 3 SUBMISSION Oct 10, 2019 Oct 10, 2019 001-39083
SC 13D Open Document Open Filing ARCH VENTURE FUND IX, L.P. - SCHEDULE 13D - KARUNA THERAPEUTICS, INC. Jul 12, 2019
4 Open Document Open Filing FORM 4 SUBMISSION Jul 2, 2019 Jul 2, 2019 001-38958
3 Open Document Open Filing FORM 3 SUBMISSION Jun 27, 2019 Jun 27, 2019 001-38958
4 Open Document Open Filing FORM 4 SUBMISSION Feb 12, 2019 Feb 12, 2019 001-38796
3 Open Document Open Filing FORM 3 SUBMISSION Feb 7, 2019 Feb 7, 2019 001-38796
D/A Open Document Open Filing Nov 18, 2016 021-259517
D Open Document Open Filing Mar 17, 2016 021-259517